Globus Medical: Q4 Revenue Tops Forecast
Globus Medical's robust earnings for Q4 2024 were driven by strategic acquisitions and sustained innovation.
Medical technologies specialist Globus Medical (NYSE:GMED) reported impressive results for the fourth quarter of 2024 on Thursday, Feb. 20. The highlights included adjusted earnings per share (EPS) of $0.84, exceeding the consensus forecast of $0.75, along with revenue that reached $657.3 million, topping expectations by $12.3 million.
Globus Medical's results underscore a strong quarter, with effective execution of strategic initiatives, notably the full integration of the September 2023 NuVasive merger.
Source: Globus Medical. Note: Analysts' consensus estimates for the quarter provided by FactSet. YOY = Year over year. EBITDA = Earnings before interest, taxes, depreciation, and amortization.
